Senior Vice President, Medical Affairs
Rezolute
Summary
Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. As we transition toward commercialization, we are seeking a strategic, visionary, and execution-oriented Senior Vice President of Medical Affairs to grow and lead a best-in-class Medical Affairs organization.
Job description
Position Summary
The Senior Vice President of Medical Affairs will provide executive leadership for all medical affairs activities across Rezolute's portfolio and pipeline, leading a team of medical affairs professionals in the development and execution of the global medical affairs strategy, generating clinical and real-world evidence, establishing therapeutic area leadership, and ensuring appropriate use of scientific and medical information before and after product launch. As a member of the Executive Leadership Team, the SVP will partner closely with Clinical Development, Regulatory Affairs, Commercial, Market Access, Pharmacovigilance, Corporate Affairs, and Investor Relations.
Key Responsibilities
Medical Affairs Leadership & Strategy
- Evaluate, develop, and execute a comprehensive global Medical Affairs strategy aligned with corporate objectives and commercialization plans.
- Grow, lead, and mentor a high-performing Medical Affairs organization, including medical leadership, medical communications, evidence generation, field medical and MSLs, and medical operations teams.
- Establish Medical Affairs as an independent, science-driven function that serves as a trusted partner internally and externally.
- Prepare the organization for successful product launch and post-launch lifecycle management.
- Serve as the senior medical affairs representative on the Executive Leadership Team and contribute to corporate and portfolio strategy.
- Communicate and validate the medical affairs strategy and plan to external stakeholders, including third-party partners and the board of directors.
External Engagement & Key Opinion Leader Development
- Translate clinical data into compelling scientific narratives for healthcare professionals, payers, patient communities, and scientific stakeholders.
- Lead interpretation and communication of clinical trial results, publications, congress presentations, and scientific exchanges.
- Support lifecycle management opportunities, label expansion strategies, and future development initiatives.
- Build and maintain relationships with academic experts, investigators, healthcare professionals, centers of excellence, and patient advocacy organizations.
- Serve as a credible scientific spokesperson at scientific congresses, advisory boards, investigator meetings, and other external forums.
- Provide leadership for KOL identification, engagement strategies, and scientific advisory board development.
- Foster partnerships with patient advocacy groups and rare disease communities.
Evidence Generation & Medical Insights
- Oversee development and execution of integrated evidence generation plans, including Phase IV studies, registries, real-world evidence programs, and investigator-sponsored research.
- Establish systems to collect, analyze, and communicate external medical insights that shape strategy and improve patient outcomes.
- Guide publication planning and scientific communications strategies.
Launch Excellence
- Partner with Commercial and Market Access teams to ensure launch readiness while maintaining compliance with applicable regulations and industry standards.
- Lead medical launch planning, scientific platform development, disease-state education initiatives, and healthcare professional engagement strategies.
- Ensure field medical teams are equipped to support the evolving needs of stakeholders before and after product launch.
Compliance & Governance
- Ensure all Medical Affairs activities comply with FDA, OIG, PhRMA, Sunshine Act, HIPAA, and applicable global regulatory requirements.
- Collaborate closely with Legal, Regulatory Affairs, Quality, and Compliance functions to maintain the highest ethical and scientific standards.
- Provide medical governance and oversight for promotional review committees and scientific communications.
Qualifications
- B.S. in a life-sciences related field, graduate degree preferred; MD, DO, PharmD, or related health professionals degree is a plus.
- Clinical and/or therapeutic area experience in Endocrinology, Pediatric Endocrinology, Metabolism, Internal Medicine, or a closely related specialty strongly preferred.
- Minimum of 15 years of biopharmaceutical industry experience, including significant leadership experience in Medical Affairs.
- Demonstrated success growing and leading Medical Affairs organizations in rare disease, endocrinology, metabolic disorders, biotechnology, or related therapeutic areas.
- Experience supporting one or more successful product launches including experience transitioning from development stage to commercial-stage organizations. Rare disease product launches are preferred.
- Proven track record of building and managing high-performing medical affairs teams.
- Strong knowledge of clinical development, regulatory requirements, scientific communications, evidence generation, and commercial launch activities.
- Exceptional executive presence and ability to engage effectively with regulators, external experts, investors, patient organizations, executive leadership, and board of directors.
- Outstanding communication and presentation skills.
Preferred Experience
- Experience in rare diseases and pediatric disorders.
- Prior leadership experience in a publicly traded biotechnology company.
- Global Medical Affairs experience.
- Demonstrated relationships within endocrinology, rare disease, or metabolic disease communities.
Leadership Competencies
- Strategic Vision
- Scientific Excellence
- Patient-Centric Mindset
- Executive Leadership
- Cross-Functional Collaboration
- Change Management
- Talent Development
- Operational Excellence
- Integrity and Ethical Judgment
- Results Orientation
Requirements
- B.S. in a life-sciences related field
- Graduate degree preferred
- MD, DO, PharmD, or related health professionals degree is a plus
- Clinical and/or therapeutic area experience in Endocrinology, Pediatric Endocrinology, Metabolism, Internal Medicine, or closely related specialty strongly preferred
- Minimum of 15 years of biopharmaceutical industry experience
- Significant leadership experience in Medical Affairs
- Demonstrated success growing and leading Medical Affairs organizations in rare disease, endocrinology, metabolic disorders, biotechnology, or related therapeutic areas
- Experience supporting one or more successful product launches
- Experience transitioning from development stage to commercial-stage organizations
- Rare disease product launches preferred
- Proven track record of building and managing high-performing medical affairs teams
- Strong knowledge of clinical development, regulatory requirements, scientific communications, evidence generation, and commercial launch activities
- Exceptional executive presence and ability to engage with regulators, external experts, investors, patient organizations, executive leadership, and board of directors
- Outstanding communication and presentation skills
- Experience in rare diseases and pediatric disorders preferred
- Prior leadership experience in a publicly traded biotechnology company preferred
- Global Medical Affairs experience preferred
- Demonstrated relationships within endocrinology, rare disease, or metabolic disease communities preferred
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Disability Insurance
- Life Insurance
- Long-Term Care Insurance
- Holiday Pay
- Tracking Free Vacation Program
- 401(k) Plan Match
- Educational Assistance
- Fitness Center Reimbursement
Company overview
Rezolute is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for metabolic diseases, with a primary focus on diabetes and related disorders. The company leverages its proprietary technology platform to create novel drug candidates that address unmet medical needs in metabolic health. Rezolute's pipeline includes promising therapeutic candidates targeting various aspects of metabolic regulation, including glucose control and insulin sensitivity. Their research approach combines deep understanding of metabolic pathways with innovative drug design to develop treatments that could potentially transform patient care in diabetes management. The company operates at the intersection of biotechnology and metabolic medicine, advancing candidates through clinical development stages with the goal of bringing effective new treatments to market for patients suffering from metabolic disorders worldwide.